Rongrong Gu

Metabolomic approach to evaluating adriamycin pharmacodynamics and resistance in breast cancer cells

Bei Cao, Mengjie Li, Weibin Zha et al. · Metabolomics · 2013 · 78 citations · Full text

Medicine, Oncology, Pharmacology +17

Metabolic phenotype of rats exposed to heroin and potential markers of heroin abuse

Linsheng Liu, Jiye Aa, Guangji Wang et al. · Drug and Alcohol Dependence · 2012 · 62 citations

Pharmacy, Pharmacology, Toxicology +16

Non-small cell lung cancer-targeted, redox-sensitive lipid-polymer hybrid nanoparticles for the delivery of a second-generation irreversible epidermal growth factor inhibitor—Afatinib: In vitro and in vivo evaluation

Jinli Wang, Gaoxing Su, Xiaoqin Yin et al. · Biomedicine & Pharmacotherapy · 2019 · 49 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Metabolic features of the tumor microenvironment of gastric cancer and the link to the systemic macroenvironment

Jiye Aa, Lianzhen Yu, Min Sun et al. · Metabolomics · 2011 · 35 citations

Medicine, Cancer Biology, Oncology +17

Pharmacokinetic interactions between 20(S)-ginsenoside Rh2 and the HIV protease inhibitor ritonavir in vitro and in vivo

Jian Shi, Bei Cao, Weibin Zha et al. · Acta Pharmacologica Sinica · 2013 · 23 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +10